April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
Aspirin-Triggered Lipoxin A4 (epi-LxA4) Is an Important Mediator for Maintaining the Integrity of Human Corneal Endothelial Cells
Author Affiliations & Notes
  • A. H. Kakazu
    Ophthalmology and Neuroscience Center of Excellence, LSU Health Sciences Center, New Orleans, Louisiana
  • J. He
    Ophthalmology and Neuroscience Center of Excellence, LSU Health Sciences Center, New Orleans, Louisiana
  • N. G. Bazan
    Ophthalmology and Neuroscience Center of Excellence, LSU Health Sciences Center, New Orleans, Louisiana
  • H. E. P. Bazan
    Ophthalmology and Neuroscience Center of Excellence, LSU Health Sciences Center, New Orleans, Louisiana
  • Footnotes
    Commercial Relationships  A.H. Kakazu, None; J. He, None; N.G. Bazan, None; H.E.P. Bazan, None.
  • Footnotes
    Support  NIH Grant EY04928
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 1818. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      A. H. Kakazu, J. He, N. G. Bazan, H. E. P. Bazan; Aspirin-Triggered Lipoxin A4 (epi-LxA4) Is an Important Mediator for Maintaining the Integrity of Human Corneal Endothelial Cells. Invest. Ophthalmol. Vis. Sci. 2009;50(13):1818.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Previous studies have shown that low concentrations of aspirin-triggered Lipoxin A4 (epi-LxA4) stimulate wound closure in rabbit corneal endothelial cells (ARVO 2008). Human endothelium has a very low mitotic rate, and with aging there is a decrease in the number of cells. Epi-LxA4 is a anti-inflammatory bioactive lipid formed when aspirin acetylates cyclooxygenease-2 (COX-2) and redirects COX-2 catalytic activity away from prostaglandins. Epi-LxA4 acts through specific G-protein coupled receptors. The purpose of the current study is to investigate the action of epi-LxA4 in human corneal endothelium.

Methods: : Human corneal endothelial cells (HCEC) along with the Descemet’s membrane were isolated from fresh human eyes obtained from NDRI. The cells were suspended in DMEN/F12 supplemented with 15% FBS. Cell phenotype was identified using ZO-1 and -SMA antibodies. LxA4 receptor was detected in HCEC and human corneal tissue using polyclonal antibody FPRL1. HCEC were starved for 24 h, then treated with 100 nM epi-LxA4 for 24 h and cell proliferation was evaluated with Ki-67 antibody. To measure wound closured in vitro, confluent HCEC were wounded by a linear scraping with a sterile pipette tip in the center of the well and incubated for 24 h and 48 h with or without epi-LxA4. Human corneas were suspended in Corneal Storage Media (Optisol GS, Bausch & Lomb) in presence of epi-LxA4 (100 nM ) and incubated at 4ºC for 10 days. The viability of the endothelial cells were assayed using LIVE/DEAD Viability/Cytotoxicity kit (Molecular Probes).

Results: : HCEC strongly expressed the FPRL1 receptor in the plasma membrane and in the nuclei. In human corneal tissue, strong positive staining was found in the endothelium. There was a three-fold increase in cell proliferation when HCEC were incubated with epi-LxA4 for 24 h. Significant endothelial wound healing was observed after 48 h incubation with epi-LxA4. Human corneas incubated for 10 days with Optisol GS in the presence of epi- LxA4 showed no toxic effects to the endothelium.

Conclusions: : Epi-LxA4 could be an important mediator for protecting the integrity of the human endothelium during corneal preservation.

Keywords: cornea: endothelium • wound healing • lipids 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×